MedKoo Cat#: 412654 | Name: CGP-42456A

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CGP-42456A - Benazepril Related Compound A, it is an Impurity. Benazepril is a prodrug which is metabolized by the liver into its active form benazeprilat via cleavage of the drug's ester group. Benazepril and Benazeprilat inhibit angiotensin-converting enzyme (ACE) in human subjects and animals. Benazeprilat has much greater ACE inhibitory activity than does Benazepril. It is indicated for the treatment of hypertension.

Chemical Structure

CGP-42456A
CGP-42456A
CAS#131064-75-0

Theoretical Analysis

MedKoo Cat#: 412654

Name: CGP-42456A

CAS#: 131064-75-0

Chemical Formula: C24H28N2O5

Exact Mass: 424.1998

Molecular Weight: 424.49

Elemental Analysis: C, 67.91; H, 6.65; N, 6.60; O, 18.84

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
CGP-42456A; Benazepril hydrochloride impurity A; CGP42456A; CGP 42456A
IUPAC/Chemical Name
((3R)-3-(((1R)-1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetic acid
InChi Key
XPCFTKFZXHTYIP-WOJBJXKFSA-N
InChi Code
InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m1/s1
SMILES Code
O=C(O)CN1C([C@H](N[C@@H](C(OCC)=O)CCC2=CC=CC=C2)CCC3=CC=CC=C31)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 424.49 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sent U, Gössl R, Elliott J, Syme HM, Zimmering T. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease. J Vet Intern Med. 2015 Nov-Dec;29(6):1479-87. doi: 10.1111/jvim.13639. Epub 2015 Oct 16. Erratum in: J Vet Intern Med. 2016 Mar- Apr;30(2):689. PMID: 26474314; PMCID: PMC4895689. 2: King JN, Martin M, Chetboul V, Ferasin L, French AT, Strehlau G, Seewald W, Smith SGW, Swift ST, Roberts SL, Harvey AM, Little CJL, Caney SMA, Simpson KE, Sparkes AH, Mardell EJ, Bomassi E, Muller C, Sauvage JP, Diquélou A, Schneider MA, Brown LJ, Clarke DD, Rousselot JF. Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial. J Vet Intern Med. 2019 Nov;33(6):2559-2571. doi: 10.1111/jvim.15572. Epub 2019 Sep 27. PMID: 31560137; PMCID: PMC6872620. 3: King JN, Christinaz C, Strehlau G, Hornfeld J. Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs. J Vet Pharmacol Ther. 2018 Jun;41(3):485-489. doi: 10.1111/jvp.12475. Epub 2018 Feb 2. PMID: 29392741. 4: Balfour JA, Goa KL. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs. 1991 Sep;42(3):511-39. doi: 10.2165/00003495-199142030-00008. PMID: 1720384. 5: DeQuattro V. Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide. Clin Cardiol. 1991 Aug;14(8 Suppl 4):IV28-32; discussion IV51-5. doi: 10.1002/clc.4960141804. PMID: 1893639. 6: Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182. PMID: 19052124. 7: Borgarelli M, Ferasin L, Lamb K, Bussadori C, Chiavegato D, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M. DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study. J Vet Cardiol. 2020 Feb;27:34-53. doi: 10.1016/j.jvc.2019.12.002. Epub 2020 Jan 10. PMID: 32032923. 8: King JN, Panteri A, Graille M, Seewald W, Friton G, Desevaux C. Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats. BMC Vet Res. 2016 Jun 23;12(1):124. doi: 10.1186/s12917-016-0734-4. PMID: 27338786; PMCID: PMC4917992. 9: Jin H, Liu ZJ, Yan CL, Liu FL, Chen L, Zhang QJ, Xu HQ, Hu JH, Dou RH, Wen XY. [The influence of benazepril and amlodipine on the expression of secretin and somatostatin in spontaneously hypertensive rats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2018 Feb 8;34(2):154-158. Chinese. PMID: 29926681. 10: Xu YY, Shen FJ, Wu LL. [Effect of benazepril on nuclear factor E2 related factor 2, nicotinamide adenine dinucleotide phosphate oxidase and reactive oxygen species in rats with hepatic fibrosis]. Zhonghua Gan Zang Bing Za Zhi. 2019 Sep 20;27(9):677-680. Chinese. doi: 10.3760/cma.j.issn.1007-3418.2019.09.004. PMID: 31594091.